Anti-Neutrophil Antibody Associated Vasculitis in Systemic Sclerosis

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 2, 2011, Pages 223-229

  Arad, Uri ^a   Balbir Gurman, Alexandra ^b   Doenyas Barak, Keren ^a   Amit Vazina, Mirit ^a   Caspi, Dan ^a   Elkayam, Ori ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Alveolar hemorrhage; ANCA; Systemic sclerosis; Vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; ETANERCEPT; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HYDROXYCHLOROQUINE; ILOPROST; IMMUNOGLOBULIN; LOSARTAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; NIFEDIPINE; PENICILLAMINE; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB; SCL 70 ANTIBODY; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESOPHAGUS DYSMOTILITY; ESOPHAGUS FUNCTION DISORDER; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; INTERSTITIAL LUNG DISEASE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIMB ISCHEMIA; LOW DRUG DOSE; LUNG HEMORRHAGE; MALE; MEDICAL LITERATURE; MEDLINE; MORTALITY; MULTIPLE CYCLE TREATMENT; PLASMAPHERESIS; POLYARTHRITIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RASH; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SKIN INDURATION; SKIN ULCER; SYSTEMIC SCLEROSIS; TELANGIECTASIA; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; FATAL OUTCOME; FEMALE; GLOMERULONEPHRITIS; HEMORRHAGE; HUMANS; LUNG DISEASES; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 80052269369     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2010.11.001     Document Type: Article

References (38)

1. Penn H., Howie A.J., Kingdon E.J., Bunn C.C., Stratton R.J., Black C.M., et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 2007, 100(8):485-494.
2. Denton C.P., Lapadula G., Mouthon L., Muller-Ladner U. Renal complications and scleroderma renal crisis. Rheumatology (Oxford) 2009, 48(Suppl 3):32-35.
3. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., de Groot K., Gross W., et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009, 68(3):310-317.
4. Casari S., Haeney M., Farrand S., Herrick A. Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis. J Rheumatol 2002, 29(12):2666-2667.
5. Wutzl A.L., Foley R.N., O'Driscoll B.R., Reeve R.S., Chisholm R., Herrick A.L. Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Rheum 2001, 45(6):533-536.
6. Akimoto S., Ishikawa O., Tamura T., Miyachi Y. Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis. Br J Dermatol 1996, 134(3):407-410.
7. Ishikawa O., Tamura T., Ohnishi K., Miyachi Y., Ishii K. Systemic sclerosis terminating as systemic necrotizing angiitis. Br J Dermatol 1993, 129(6):736-738.
8. Locke I.C., Worrall J.G., Leaker B., Black C.M., Cambridge G. Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol 1997, 24(1):86-89.
9. Ruffatti A., Sinico R.A., Radice A., Ossi E., Cozzi F., Tonello M., et al. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol 2002, 29(5):918-923.
10. Endo H., Hosono T., Kondo H. Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994, 21(5):864-870.
11. Huong D.L., Papo T., Gatfosse M., Frances C., Godeau P., Beaufils H. Antineutrophil cytoplasmic autoantibodies in systemic sclerosis with renal failure. J Rheumatol 1995, 22(4):791-792.
12. Omote A., Muramatsu M., Sugimoto Y., Hosono S., Murakami R., Tanaka H., et al. Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies-related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med 1997, 36(7):508-513.
13. Karpinski J., Jothy S., Radoux V., Levy M., Baran D. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature. Am J Nephrol 1997, 17(6):528-532.
14. Hillis G.S., Khan I.H., Simpson J.G., Rees A.J. Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies. Am J Kidney Dis 1997, 30(2):279-281.
15. Carvajal I., Bernis C., Sanz P., Garcia A., Garcia-Vadillo A., Traver J.A. Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis. Nephrol Dial Transplant 1997, 12(3):576-577.
16. Anders H.J., Wiebecke B., Haedecke C., Sanden S., Combe C., Schlondorff D. MPO-ANCA-positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease?. Am J Kidney Dis 1999, 33(4):1-3.
17. Katrib A., Sturgess A., Bertouch J.V. Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure. Rheumatol Int 1999, 19(1-2):61-63.
18. Villaverde V., Balsa A., Cabezas J.A., Fernandez-Prada M., Torre A., Mola E.M. Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic autoantibodies which developed into Paget's disease of bone after immunosuppressive therapy. Rheumatology (Oxford) 1999, 38(2):190-191.
19. Yamashita K., Yorioka N., Kyuden Y., Naito T., Tanji C., Ueda C., et al. A case of CREST syndrome and myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis. Clin Nephrol 2000, 53(4):296-300.
20. Maes B., Van Mieghem A., Messiaen T., Kuypers D., Van Damme B., Vanrenterghem Y. Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type. Am J Kidney Dis 2000, 36(3):1-5.
21. Tomioka M., Hinoshita F., Miyauchi N., Akiyama Y., Saima S., Hiroe M. ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension. Intern Med 2004, 43(6):496-502.
22. Herrera-Esparza R., Aguilar J.L., Saucedo A., Gonzalez I., Lopez-Robles E., Avalos-Diaz E. Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum. J Eur Acad Dermatol Venereol 2005, 19(5):617-620.
23. Kamen D.L., Wigley F.M., Brown A.N. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma-a different kind of renal crisis. J Rheumatol 2006, 33(9):1886-1888.
24. Rho Y.H., Choi S.J., Lee Y.H., Ji J.D., Song G.G. Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int 2006, 26(5):465-468.
25. Arnaud L., Huart A., Plaisier E., Francois H., Mougenot B., Tiev K., et al. ANCA-related crescentic glomerulonephritis in systemic sclerosis: revisiting the "normotensive scleroderma renal crisis". Clin Nephrol 2007, 68(3):165-170.
26. Cheung G., Chew G., Wyndham R., Peters M., Riminton S. Myeloperoxidase-antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl-70-positive scleroderma. Intern Med J 2007, 37(3):205-207.
27. Ramaswami A., Kandaswamy T., Rajendran T., Jeyakrishnan K.P., Aung H., Iqbal M., et al. Scleroderma with crescentic glomerulonephritis: a case report. J Med Case Rep 2008, 2:151.
28. Akkara Veetil B.M., Schimmer B.M. A case of limited systemic sclerosis with p-ANCA, complicated by multiple cerebral hemorrhages. Rheumatol Int 2009, 29(3):325-329.
29. Bartoloni Bocci E., Giordano A., Luccioli F., Alunno A., Gerli R. Crescentic glomerulonephritis and circulating antineutrophil cytoplasmic antibodies in scleroderma: a case report and review of the literature. Clin Exp Rheumatol 2009, 27(2):385-386.
30. Kiraz S., Simsek H., Ertenli I., Benekli M., Kadayifci A. Antineutrophil cytoplasmic antibodies in systemic sclerosis. Clin Rheumatol 1996, 15(5):519-520.
31. Kumakura S., Ishikura H., Kondo M., Murakawa Y., Kobayashi S. Hemophagocytosis associated with MPO-ANCA positive vasculitis in systemic sclerosis. Clin Exp Rheumatol 2002, 20(3):411-414.
32. Mimura I., Hori Y., Matsukawa T., Uozaki H., Tojo A., Fujita T. Noncrescentic ANCA-associated renal crisis in systemic sclerosis. Clin Nephrol 2008, 70(2):183-185.
33. Wong M., Ranganath V.K., Clements P.J. Antineutrophil cytoplasmic antibody-positive digital necrosis in a patient with limited systemic sclerosis. J Rheumatol 2010, 37(1):214-215.
34. Steen V.D. Epidemiology and classification of scleroderma. Rheumatology 2008, 1361-1367. Mosby-Elsevier, St. Louis (MO). M.C. Hochberg, A.J. Silman, J.S. Smolen (Eds.).
35. Teixeira L., Mouthon L., Mahr A., Berezne A., Agard C., Mehrenberger M., et al. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis 2008, 67(1):110-116.
36. Jones R.B., Ferraro A.J., Chaudhry A.N., Brogan P., Salama A.D., Smith K.G., et al. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2009, 60(7):2156-2168.
37. Stone J.H., Merkel P.A., Spiera R., Seo P., Langford C.A., Hoffman G.S., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363(3):221-232.
38. Jones R.B., Tervaert J.W., Hauser T., Luqmani R., Morgan M.D., Peh C.A., et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 2010, 363(3):211-220.